Study challenges neo-liberal higher education model by revisiting Confucius’ dual ideals of the ideal individual and social order
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Mar-2026 08:16 ET (30-Mar-2026 12:16 GMT/UTC)
Chinese researchers identified tumor-specific MHC-II (tsMHC-II) expression as a novel biomarker predicting response to neoadjuvant immunotherapy in gastric cancer. Single-cell profiling revealed higher MHC-II expression in tumor cells from treatment-sensitive patients. Validated in prospective trials, tsMHC-II-positive patients achieved 36.67% pathological complete response rate versus low rates in unselected populations. This simple immunohistochemistry-based biomarker outperforms current PD-L1 assessment and could guide personalized therapy for gastric cancer patients.